Harvest and purification treatments that eliminate cells, mobile debris and media factors even though defending the intermediate or API from contamination (notably of a microbiological character) and from loss of high qualityRaw materials Employed in manufacture of APIs for use in clinical trials need to be evaluated by tests, or obtained by using